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Diagnosing congenital toxoplasmosis: where are we? 
A systematic review
 REVIEW 
Maria do Socorro Vieira dos Santos1,2, Cláudio Gleidiston Lima da Silva1,2, 
Pedro Neto Lima de Oliveira1, Karla Denise Barros Ribeiro1, Antonio Gilvan Teixeira Júnior1,3, 
Matheus Felipe Aguiar Santos1, Victor Hugo Gonçalves Lopes1,3, 
Modesto Leite Rolim-Neto1, Bianca Bianco2, Anete Sevciovic Grumach2
Abstract
Purpose: Compile information on laboratory methods for diagnosis 
of congenital toxoplasmosis, considering the tests conducted since 
the gestational stage until the child period.
Methods:A systematic review of 01.01.2006 to 31.12.2013 was 
held by VHL (Virtual Health Library). The search was performed with 
the descriptors ''toxoplasmosis” and “diagnosis. The selected articles 
were indexed in MEDLINE. The information pertinent to the study 
was selected, categorized and analyzed. Of the 186 articles found, 
41 met the eligibility criteria.
Results: Laboratory tests are based on the presence of antibodies 
IgM and IgG anti-Toxoplasma gondii, in this sense it is important to 
correctly interpret serology, because the detection of specific antibo-
dies is often delayed by the presence of maternal IgG or late produc-
tion of specific antibodies in newborns. Molecular techniques (PCR) 
have emerged as alternative due to its higher sensitivity and specificity 
in diagnosing instruments, given the ability to detect parasite DNA 
and non-dependence of the immune response of the patient, such 
as serological tests.
Conclusions: The need for early treatment of congenital toxoplas-
mosis in order to avoid sequelae justifies the search for more sensitive 
and specific laboratory tests in early detection of the parasite. The 
integration among the different levels of care in the public health 
system is essential for obtaining effective control of toxoplasmosis in 
pregnant women.
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Introduction
Toxoplasmosis is a worldwide zoonosis caused by 
Toxoplasma gondii, an intracellular protozoan of a 
het-eroxenic life-cycle that is capable of infecting 
a variety of warm-blooded vertebrates [1]. Primary 
infection is most often asymptomatic in healthy 
individuals, and a symptom free chronic infection 
is established. Nevertheless, essentially in two cir-
cumstances, a life-threatening disease may occur in 
reactivation in immunecompromised patients (HIV-
infected patients or transplant recipients) and in pri-
mary infection during pregnancy, which is followed 
in about one-third of the cases by an infection of 
the fetus [2].
During the primary infection acquired during 
pregnancy, the effective parasite transmits to fe-
tus through placenta, causes congenital infection 
and various sequels [3]. Placental transfer was the 
first known transmission way of Toxoplasma gon-
dii. The fetus is usually infected by tachyzoites that 
cross the placenta from the maternal circulation 
during primary infection but dormant tissue cysts 
of past infection may restart the life cycle of the 
parasite in immunossupressed pregnant women 
and, in rare cases, in immunocompetent pregnant 
women. Reinfection has more recently been ob-
served [4].
Primary maternal Toxoplasma infection may be 
health-threatening for the fetus, or may even cause 
death in utero, depending on the date of transmis-
sion, parasite burden, parasite genotype, and host 
susceptibility [5]. The chances of fetal infection by T. 
gondii increase with the stage of pregnancy, from 
5-15% in the first half of gestation, to 60-80% in 
the second half. Conversely, the chances of serious 
lesions and death decrease, declining from 70-80% 
in the first half to less than 10% in the second 
half [6, 7]. The clinical picture is notably variable 
in congenital toxoplasmosis. While sometimes no 
symptoms or findings are seen, spontaneous abor-
tions and stillbirth may occur. The most frequent 
findings are chorioretinitis, intracranial calcifications 
and hydrocephalus. In the babies born as asymp-
tomatic, hearing and visual impairment, neurologic 
findings and mental retardation may develop after 
long years [3]. 
Neonates with congenital toxoplasmosis, even as-
ymptomatic at birth, should be treated early to redu-
ce long-term sequelae. Postnatal diagnosis of con-
genital toxoplasmosis is essential because prenatal 
diagnosis fails to detect approximately 15% of cases 
or cannot be performed when maternal infection is 
acquired in late pregnancy. Detection of parasites in 
the placenta is one diagnostic approach to the early 
neonatal diagnosis of congenital toxoplasmosis [8]. 
The need for an early treatment of congenital toxo-
plasmosis to avoid late sequelae justifies the search 
for more sensitive and specific assays to detect T. 
gondii infection as early as possible [9].
The objective of this review was to compile in-
formation on laboratory methods for diagnosis of 
congenital toxoplasmosis, considering the tests con-
ducted since the gestational stage until the child 
period. In this context, it analyzes the interpretation 
of a preventive diagnosis in reducing clinical cases 
at a later age.
Methods 
It was performed a qualitative systematic review of 
articles about diagnosis of toxoplasmosis published 
in electronic databases previously selected. It was 
conducted a search in the literature through the on-
line databases of the Virtual Health Library (VHL), 
that hosts the base of MEDLINE, in August 2014, by 
limiting itself to articles published between January 
1, 2006 to December 31, 2013.
The reason to limit the search between 2006 and 
2013 was because before this period, the number 
of published works were little expressive and at the 
same time not addressed directly to diagnosis of 
toxoplasmosis.
The following descriptors were used, in Portugue-
se, for searching in the VHL:
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#1.“  toxoplasmosis’’ (Descriptors in Health Scien-
ces [DeCS, in Portuguese]);
#2.“ diagnosis’’(DeCS term);
A similar search strategy was held in the Pub-
Med database, by using the same terms mentioned 
above.
 The analysis of the article followed eligibility cri-
teria previously determined. The survey was carried 
out in one phase: 1 AND 2. A search was conduc-
ted for those combinations by using the filter “title, 
abstract, subject”. 
It was adopted the following inclusion criteria: 
(1) written publications in English, in Spanish or 
in Portuguese. (2) studies about the diagnosis of 
toxoplasmosis; (3) subject page Congenital Toxo-
plasmosis human limit; (4) human limit; (5) original 
articles with full text accessible through the Portal 
de Periodicos CAPES (The Coordination of Impro-
vement of Higher Education Personnel) a virtual 
library connected to the Brazilian Ministry of edu-
cation with content restricted to authorized users; 
and (6) prospective or retrospective observational 
studies (descriptive or analytical, except for case 
studies), experimental or almost experimental. The 
exclusion criteria were: (1) other study designs, e.g. 
case reports, case series, literature reviews and 
comments; (2) non-original studies, including edi-
torials, reviews, forewords, short communications 
and letters to the editor.
Each article was read in its entirety, and the in-
formation was entered in a spreadsheet that inclu-
ded authors, year of publication, the study sample 
description, key data, and databases. Some stu-
dies found about diagnosis of toxoplasmosis, trea-
ted them only the epidemiology of toxoplasmosis 
in certain regions, about treatment and costs, 
prognosis, adherence to screening for toxoplas-
mosis in pregnancy, toxoplasmosis in twins, eye, 
brain, auditory manifestations in neonates, risk 
factors for toxoplasmosis, toxoplasmosis caused 
by aftermath. To better analyze the data, the fo-
llowing stage involved the comparison between 
the articles and the division of the results obtai-
ned from the reading of each one of them in 
four categories: methods of diagnosis, diagnosis 
in pregnant women, neonatal diagnostics and in-
fants diagnosis.
Results 
Initially, the aforementioned search strategies re-
sulted in 186 references. After browsing the title 
and abstract of the retrieved citations for eligibility 
based on study inclusion criteria, 145 articles were 
excluded and 41 articles were further retrieved and 
included in the final sample (Figure 1). Articles from 
MEDLINE database matched the inclusion criteria of 
the present study.
Table 1 provides an overview of all studies inclu-
ded in the final sample and of all data elements 
used during the data analysis process. The 41 
studies were distributed into the previously deter-
mined three categories as follows: DIAGNOSTIC 
METHODS [2, 4, 5, 8, 9, 12, 14, 16, 17, 20, 25, 
27, 29, 32, 34, 35, 37, 41, 42 (nineteen studies)]; 
DIAGNOSIS IN PREGNANT WOMEN [ 3, 7, 10, 14, 
25, 27, 35, 42, 46, 50, 51, 53, 59 thirteen studies)]; 
DIAGNOSIS IN NEONATES [7, 8, 11, 20, 61, 64, 65, 
67, 68, 70, 71, 72 (twelve studies)] and DIAGNOSIS 
IN INFANTS [1, 3, 5, 9, 11, 12, 20, 27, 32, 42, 67, 
68, 72, 78, 79, 85, 87 (seventeen studies)]. Among 
the 41 studies, some studies were referenced in 
more than one category. The categorization of 
studies aims to a better organizational quality sys-
tematic review and it is not compulsory that each 
article must be referenced only in their respective 
category
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Figure 1: Flow chart showing study selection for the review.
VHL
"Toxoplasmose" (DeCS term) AND "Diagnóstico" (DeCS 
term)
Index: title, abstract, subject
Period: 01.01.2006 to 31.12.2013
Inclusion criteria
1.  References written 
in english, spanish or 
portuguese; 
2.  Studies related to the 
diagnosis of congeintal 
toxoplasmosis;
3.  Original articles with 
accessible full tex online;
4.  Oservational (analytical or 
descriptive, accept case 
reports), experimental or 
quasi-experimental sutdies, 
both prospective and 
retrospective.
145 references excluded after 
examining title and abstract:
1.  Not about toxoplasmosis 
con genital diagnosis  
(n= 65);  
2. Case report (n= 30); 
3.  Abstract or Full Text not 
available (n= 13); 
4. Repeated article (n= 10); 
5. Editorial (n= 5); 
6. Review article (n= 17);  
7. Informative (n= 1);  
8.  Short communication  
(n= 2);  
9. Correpondence (n= 1);  
10. Clinicla Picture (n= 1)  
Full-text references 
assessed for eligibility
(n= 41)
Studies included 
in this review 
(n=41)
186 results
Abbreviations:  VHL: Virtual Health Library; DeCS: Health Sciences Descriptors
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Table 1. Studies and main findings.
Authors Journal Sample Main findings
Teixeira 
et al. 
(2013)
Rev Soc 
Bras Med 
Trop
One hundred pregnant women 
who seroconverted during 
pregnancy were included in 
the study. The definition of 
cases was based on a 12-month 
follow-up of the infants.
The conventional PCR assay detected 50 cases (9 false-
negatives), nested-PCR detected 58 cases (1 false-
negative and 4 false-positives), multiplex-nested-PCR 
detected 57 cases (2 false-negatives), and real-time-PCR 
detected 58 cases (1 false-negative). The real-time PCR 
assay was the best-performing technique based on the 
parameters of sensitivity (98,3%), specificity (100%), 
positive predictive value (100%), negative predictive 
value (97,6%), positive likelihood ratio (∞), negative 
likelihood ratio (0.017R) and efficiency (99%).
Costa et 
al. (2013)
J Clin 
Microbiol
Peripheral blood samples from 150 
children diagnosed with congenital 
toxoplasmosis were collected 
during confirmatory tests, when 
children had an average age of 
55.8 ± 15.8 days old.
We conclude that T. gondii qPCR positivity is higher in 
infants with ocular involvement, particularly in those with 
active retinochoroiditis.The parasite load in peripheral 
blood of congenitally infected infants within the first 
2 months of life is low, with no association between 
degree of parasitemia and the presence of retinochoroidal 
lesions.
Torres et 
al. (2013)
Pediatr Infect 
Dis J
Peripheral blood samples were 
collected from mothers and 
children during the infants’ first 3 
months of life and were referred 
to the “Centro de Investigaciones 
Biomédicas” at the University 
of Quindio for confirmatory 
serological tests.
Twenty-three children were defined as infected 
congenitally by the persistence of IgG anti-Toxoplasma 
titers during follow-up or by the other criteria proposed 
by the European Network on Congenital Toxoplasmosis 
(ENCT). Thirty-one children were uninfected as 
determined by the disappearance of IgG during follow-
up in the absence of treatment. Our results show that 
prenatal treatment significantly reduces the sensitivity of 
confirmatory assays.
Delhaes 
et al. 
(2013)
Diagn 
Microbiol 
Infect Dis
We evaluated the performance 
of three real-time polymerase 
chain reaction (PCR) assays on 73 
samples from mothers and children 
with congenital toxoplasmosis.
In this study, we observed the better detection rate of PCR 
targeting the 529-bp repeat element than PCR targeting 
the B1 gene in the context of CT diagnosis. We showed 
a higher sensitivity of PCR in this diagnosis during the 
prenatal period than the birth period when testing AF and 
blood samples. This could account for the lower detection 
rate of PCR in children born to treated mothers and to a 
better performance of PCR on prenatal AF.
Wallon 
et al. 
(2013)
Clin Infect 
Dis
We analyzed data from pregnant 
women diagnosed with acute 
Toxoplasma infection in Lyon 
(France) from 1987 to 2008 
and assessed how the risks of 
congenital toxoplasmosis and of 
clinical signs at age 3 years vary 
depending on GA at the time of 
maternal infectin.
These analyses demonstrated that introduction of monthly 
prenatal screening and improvement in antenatal diagnosis 
were associated with a significant reduction in the rate of 
congenital infection and a better outcome at 3 years of 
age in infected children.
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Authors Journal Sample Main findings
Uysal et 
al. (2013)
Rev Med 
Chile
To study the seroprevalence of 
Toxoplasma gondii infection 
among pregnant women living in 
lzmir, Turkey. A blood sample was 
obtained from 4651 women aged 
between 15 and 45 years, during 
their first trimester of pregnancy.
IgG antibodies were positive in 1871 (39.9%) participants. 
Of these, 48 (2.5%) also had positive IgM antibodies. In 41 
of these 48 women, the IgG avidity test was performed 
and only one woman had a low avidity. Her offspring had 
an intrauterine growth retardation and oligohydramnios. 
A chorioretinitis was diagnosed in the offspring of other 
woman with both antibodies positive. In this series, the 
prevalence of congenital toxoplasmosis was low. However, 
women with positive antibodies against Toxoplasma 
Gondii should be further studied and followed during their 
pregnancy.
Prusa et 
al. (2013)
Neonatology In this prospective observational 
study, 5.545 consecutive women 
were included over a 19-month 
period. Routine prenatal maternal 
toxoplasmosis serology screening 
was performed along with 
additional cord blood serology 
screening at delivery.
Based on the initial prenatal maternal screening serology 
results, there was evidence of a prior chronic infection 
manifest in 1,830 (33.0%) women and 3,708 (66.9%) 
were not infected. Seven (0.13%) were diagnosed with 
acute toxoplasma infection based on seroconversion. 
Identification of Toxoplasma gondii infection by prenatal 
maternal serological testing is significantly improved by 
the addition of maternal and/or fetal serological testing at 
birth.
Sterkers 
et al. 
(2012)
J Clin 
Microbiol
From a prospective cohort of 344 
women who seroconverted for 
toxoplasmosis during pregnancy, 
344 amniotic fluid, 264 placenta, 
and 216 cord blood samples were 
tested for diagnosis of congenital 
toxoplasmosis using the same PCR 
assay.
In total, our experience confirms the usefulness and 
accuracy of a high-performance-level molecular diagnosis 
to detect congenital toxoplasmosis, both prenatally 
and at birth. The novelty of our study relies upon the 
consideration of the curves of pre- and posttest risks 
obtained from this molecular diagnosis for estimation of 
the actual risk of congenital toxoplasmosis throughout the 
course of pregnancy.
Morelle 
et al 
(2012)
J Clin 
Microbiol.
This evaluation was based upon 
a T. gondii DNA serial dilution 
assay, three amniotic fluid 
samples spiked with T. gondii at 
different concentrations, and a 
clinical cohort of 33 amniotic fluid 
samples. The T. gondii DNA serial 
dilution assay showed a much 
lower sensitivity for the commercial 
kit.
We compared the performances of three molecular 
methods for the detection of Toxoplasma gondii DNA 
in amniotic fluid: a commercial method using nested 
PCR and two laboratory-developed methods, one using 
conventional PCR and the other one real-time PCR. This 
study emphasizes that commercial PCR diagnostic kits do 
not systematically perform better than carefully optimized 
laboratory-developed methods. There is a need for 
thorough evaluation of such kits by proficient groups, as 
well as for performance standards that commercial kits can 
be tested against to improve confidence in those selected 
by health care providers.
Prusa et 
al. (2012)
Clin Vaccine 
Immunol.
In a retrospective study, serum 
Toxoplasma gondii antibodies were 
measured in samples from 333 
infants, including 212 noninfected 
infants and 121 infants with 
congenital toxoplasmosis. A total 
of 1.157 umbilical cord blood and 
peripheral serum samples were 
analyzed.
All noninfected infants were seronegative by Liaison IgG 
within the first year of life. The Liaison system showed a 
sensitivity of 81.8%, a specificity of 100.0%, a positive 
predictive value of 100.0%, a negative predictive value of 
90.6%, and overall agreement of 84.4% by comparison 
with the dye test. Overall agreement of both IgM test 
systems was 96.0%. The Liaison system is a valuable tool 
to monitor the serologic course of infants at risk. A final 
serologic confirmatory test is recommended to improve 
the rate of detection of congenital toxoplasmosis at 1 
year of life.
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Authors Journal Sample Main findings
L'Ollivier 
et al. 
(2012)
Clin Vaccine 
Immunol.
The study was performed on 
236 mother-child serum pairs 
collected from 1999 to 2010 at 
the parasitology laboratories of the 
university hospitals of Lyon and 
Marseille.
Our findings demonstrate that taking high-molecular-
mass bands into account greatly improves the sensitivity 
of the test without yielding false-positive results. The 
biologists who interpret immunoblot profiles should 
be particularly aware of the great diagnostic value of 
this three-IgM-band association at 75, 90, and 100 
kDa, called the IgM triplet. In our series, this specific 
association markedly improved the performance of this 
test with a resulting sensitivity of 95.8% when combined 
with prenatal and conventional serological neonatal 
tests without loss of specificity. Despite the significant 
progress brought about by the analysis of these additional 
immunoblot bands, postnatal follow-up remains, 
however, necessary in the first year of life to fully identify 
infected children.
Faucher 
et al. 
(2012)
Eur J Clin 
Microbiol 
Infect Dis.
To optimize NucliSens easyMAG, 
we evaluated the addition of 
proteinase K pre-treatment and 
the increase of the amount of silica 
particles used for the extraction. 
The optimized method was then 
compared to QIAamp DNA minikit 
on samples containing less than 25 
tachyzoites/ml.
The optimized method yielded more positive PCRs than 
the manual method, especially for samples containing 5 
tachyzoites/ml or less (71% vs 26%, p<10-4). The DNA 
amount in samples found positive by PCR was higher 
after optimized automated extraction than after manual 
extraction (p<10-4). Proteinase K pre-treatment should be 
added to extract DNA from amniotic fluid using NucliSens 
easyMAG. Using this optimized automated method rather 
than manual methods would improve the sensitivity of 
Toxoplasma PCR and simplify the daily workflow.
Silva et 
al. (2012)
Mem Inst 
Oswaldo 
Cruz
Sera from 217 newborns initially 
testing positive for specific IgM 
in filter paper dried blood spots 
were tested for specific IgM and 
IgG by ELFA-VIDAS®. Congenital 
toxoplasmosis was confirmed in 
175 and ruled out in 42 infants.
Congenital toxoplasmosis was confirmed in 175 and 
ruled out in 42 infants. The validity of the ELISA tests 
was determined using the persistence of IgG antibodies 
(ELFA-VIDAS® kit) at the end of 12 months, which 
is considered the reference test for the diagnosis of 
congenital toxoplasmosis. All of the antigens showed high 
sensitivity and low specificity in detecting anti-T. gondii 
IgGt and IgG1 and low sensitivity and high specificity in 
detecting IgG3 and IgG4. The combined detection of 
IgG antibody subclasses against recombinant toxoplasmic 
antigens may be useful for the early diagnosis of congenital 
toxoplasmosis.
Liu et al. 
(2012)
Foodborne 
Pathog Dis.
The recombinant antigen of 
ROP2186–533 was applied for 
diagnosis of both human and 
mouse serum samples using 
enzyme-linked immunosorbent 
assay (ELISA).
In summary, Toxo-IgM and -IgG antibodies in the sera 
of suspected Toxoplasma infection were examined and 
the antibody kinetics in mice infected with PRU strain of 
T. gondii with the rROP2186–533 antigen in ELISA were 
analyzed. The data showed that the rROP2186–533 was 
an efficient diagnostic antigen for detection of Toxo-
IgM antibodies compared with WSA. It could be used 
as a specific antigen to capture Toxo-IgM antibodies 
for serodiagnosis of congenital toxoplasmosis and for 
differentiating between recent and latent infections.
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Said et 
al. (2011)
J Trop Pediatr We prospectively studied 80 
preterm neonates, recruited 
from neonatal intensive care 
units (NICUs) of Cairo University 
hospitals. Whose gestational age 
34 weeks with (n=60) or without 
(n=20) CT risk. Serum samples 
for specific IgA, IgM antibodies 
and avidity of IgG toxoplasma 
antibodies were measured by 
ELISA then compared to PCR.
Of the 60 studied cases, 16 (26.7%) were positive for 
toxoplasmosis by PCR, of which 15 (25%) had low avidity 
of IgG antibodies (positive), 14 (23.3%) were positive for 
IgA and 10 (16.7%) were positive for IgM, with sensitivity 
for avidity of IgG, IgA and IgM: 93.2%, 87.5% and 62.5%, 
respectively. Determination of avidity of IgG toxoplasma 
antibodies and/or serological detection of specific IgA for 
toxoplasmosis offer, simple tests for diagnosis of congenital 
toxoplasmosis with (better sensitivity) than IgM.
Pessanha 
et al. 
(2011)
Rev. Paul. 
Pediatr
This cross-sectional retrospective 
study from 2003 to 2006 enrolled 
98 pregnant women with positive 
IgM test for toxoplasmosis and 
99 children. The follow-up of the 
children with or without congenital 
infection was reviewed, as well as 
the clinical presentation of those 
with congenital infection and the 
laboratory tests used to diagnose 
the infection by Toxoplasma gondii 
during pregnancy.
The results of this research suggest that, for the diagnosis 
of acute T. gondii infection in pregnancy should always 
consider holding the IgG avidity test in the first trimester in 
pregnant women with positive IgM serology. The presence 
of positive IgM serology as a test isolated, has limited 
value for detecting recent infection and should be used 
in combination with other complementary tests for the 
diagnosis of acute infection.
Sterkers 
et al. 
(2011)
Diagn 
Microbiol 
Infect Dis
In a cohort of 12 consecutive 
neonates, polymerase chain 
reaction (PCR) established the 
diagnosis of 5 of 6 cases of 
congenital toxoplasmosis and did 
so earlier than serologic methods.
In conclusion, with a low false-negative rate and no 
false positive result, we validated that PCR on neonatal 
peripheral blood i) can be performed routinely, ii) is able to 
affirm the diagnosis of CT, and iii) may be the first positive 
examination. Therefore, this unusual practice appears to be 
a useful alternative diagnostic approach.
di Carlo 
et al. 
(2011)
Acta 
Pharmacol 
Sin
Eighty five mothers with 
Toxoplasma seroconversion and 
their offspring were enrolled 
(among them, 2 spontaneous 
abortions were documented in 
the first trimester). Prenatal PCR 
diagnosis was carried out on 50 
patients (60%), with 7 positive 
cases (14%). Morphological 
ultrasound scanning revealed 
anomalies in one fetus.
Western blot analysis may help to evaluate infection within 
the 6 months of life. The accuracy of ultrasound imaging 
to determine the brain damage in the fetus and newborns 
is doubtful, and should be combined with MR imaging. 
Multistep approaches can improve the timing of postnatal 
follow-up.
Gómez-
Marin et 
al. (2011)
PLoS Negl 
Trop Dis
We collected 15,333 samples from 
umbilical cord blood between 
the period of March 2009 to May 
2010 in 19 different hospitals and 
maternal-child health services from 
seven different cities. We applied 
an IgM ELISA assay (Vircell, Spain) 
to determine the frequency of IgM 
anti Toxoplasma
61 positive samples for specific IgM (0.39%) and 9 positives 
for IgA (0.5%) were found. 143 questionnaires were positive 
for a clinical diagnosis or treatment for toxoplasmosis during 
pregnancy. 109 out of the 218 children that had some of 
the criteria for postnatal confirmatory tests were followed. 
Congenital toxoplasmosis infection was confirmed in 15 
children: 7 were symptomatic, and three of them died 
before the first month of life (20% of lethality). A significant 
correlation was found between a high incidence of markers 
for congenital toxoplasmosis and higher mean annual 
rainfall for the city.
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Magi, 
B and 
Migliorini, 
L. (2011)
New 
Microbiol
Fifty-six mother-child pairs were 
enrolled in the study, in the period 
2001-2008. All pregnancies 
had a regular course, without 
clinical signs of pathology due to 
Toxoplasmainfection. None of the 
babies had clinical manifestations 
suggesting congenital 
toxoplasmosis.
We can therefore conclude that of the several serological 
tests used to detect congenital toxoplasmosis Western blot 
was the most sensitive, demonstrating IgM with a greater 
sensitivity than the ISAGA technique and being the only 
technique to differentiate IgG of maternal origin from that 
of fetal and neonatal origin.
Malinger 
et al. 
(2011)
Mem Inst 
Oswaldo 
Cruz
The aim of this study was to 
evaluate the utility of western 
blot (WB) analysis as a diagnostic 
tool for congenital toxoplasmosis 
in 215 newborn infants. The 
children were submitted to clinical 
examinations to assess macular, 
neurological and hearing signals.
This work showed that the WB assay is an effective tool 
for confirming the diagnosis of infants clinically suspected 
of congenital toxoplasmosis. The difference in the 
standard of antigen recognition observed in this work may 
indicate a differentiated profile of antibodies in response 
to the differential antigenic constitutions of the isolates 
predominating in Brazil. An association between WB 
results and clinical diagnosis of infants was demonstrated 
for the first time, with the IgM-WB test result likely being 
an indicator of macular lesions in newborn infants.
Roc et al. 
(2010)
Enferm 
Infecc 
Microbiol 
Clin
Toxoplasmosis seroprevalence 
was analyzed in 68.712 serum 
samples from 47.635 pregnant 
women living in the catchment 
area of Hospital Miguel Servet 
during the period of 1992 to 2008. 
Detection of toxoplasma-specific 
immunoglobulins (IgM, IgA, IgG) 
and IgG avidity studies were 
carried out in the microbiology 
laboratory.
The cases of congenital toxoplasmosis were detected by 
maternal seroconversion during pregnancy. IgA was the 
most sensitive marker for the detection of congenital 
infection in neonates.
Wallon 
et al. 
(2010)
Obstet 
Gynecol
This was a prospective cohort 
study of women with Toxoplasma 
infection identified by prenatal 
screening in three centers routinely 
carrying out real-time PCR for the 
detection of Toxoplasma gondii in 
amniotic fluid.
Polymerase chain reaction analysis was carried out on 
amniotic fluid for 261 of the 377 patients included (69%). 
Real-time PCR analysis significantly improves the detection 
of T. gondii on amniotic fluid. It provides an accurate tool 
to predict fetal infection and to decide on appropriate 
treatment and surveillance. However, postnatal follow-up 
remains necessary in the first year of life to fully exclude 
infection in children for whom PCR results were negative.
Souza-
Júnior et 
al. (2010)
Sci. Med A cross-sectional study included 
pregnant women with serological 
diagnosis of acute toxoplasmosis 
(presenting a positive Toxoplasma 
gondii-specific IgM test) attended 
at the outpatient unit for high-
risk pregnancy of the Faculty of 
Medicine, Federal University of 
Mato Grosso do Sul, Brazil, in the 
period from November 2002 to 
November 2007.
In this study the rate of congenital infection in pregnant 
women diagnosed with acute toxoplasmosis was 4%. In 
pregnant women with positive Toxoplasma gondii-specific 
IgM, results of Toxoplasma gondii-specific IgG avidity 
test were associated with the presence or absence of 
congenital infection, with a high negative predictive value 
(no fetal/neonatal infection when avidity was high).
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Chapey 
et al. 
(2010)
J Clin 
Microbiol
Patient group 1 was used in a pilot 
study to check the validity of the 
technique before the testing of 
infants. It included 172 patients 
consulting in the outpatient 
department at Hospital de la Croix 
Rousse, Lyon, France, and pregnant 
women tested for toxoplasmosis 
serology as part of the French 
national program of prevention to 
PHA stimulation or spontaneous 
secretion of IFN- Group 2 
consisted of 62 infants under 1 
year of age who were born to 
mothers who seroconverted during 
pregnancy. Group 3 comprised 
124 congenitally infected patients 
enrolled at ages 1 to 30 years.
We demonstrated that evaluation of the IFN-response 
after stimulation of whole blood by crude toxoplasmic 
antigen is a simple, easily performed test that is suitable 
for diagnosing congenital toxoplasmosis in newborns. This 
test could reliably rule out congenital infection at birth and 
avoid unnecessary anxiety and serological follow-up. The 
use of purified antigens or synthetic peptides to improve 
the performance of the test should be investigated.
Robert-
Gangneux 
et al. 
(2010)
Pediatr Infect 
Dis J
We examined 102 placentas 
which were sent to our laboratory 
between February 2003 and April 
2008, for T. gondii detection 
within the framework of neonatal 
screening performed routinely 
in France in cases of maternal 
Toxoplasma infection during 
pregnancy.
Parasites were detected more often when maternal 
infection was acquired during the third trimester of 
pregnancy (P < 0.01), regardless the type of treatment. 
The sensitivity of IgM detection appeared to be related 
to maternal treatment since IgM was positive in 43% and 
75% when mothers were treated or not, respectively (P < 
0.01). Placental examination is an efficient tool for the early 
diagnosis of congenital toxoplasmosis.
Rodrigues 
et al. 
(2009)
Mem Inst 
Oswaldo 
Cruz
In a prospective longitudinal 
study, 50 infants with suspected 
congenital toxoplasmosis were 
followed up in the ambulatory care 
centre of Congenital Infections 
at University Hospital in Goiânia, 
Goiás, Brazil, from January 1st, 
2004 to September 30th, 2005.
The results showed that 28/50 infants were infected. 
During the neonatal period, IgM was detected in 39.3% 
(11/28) of those infected infants and IgA was detected 
in 21.4% (6/28). The presence of specific IgM and IgA 
antibodies during the neonatal period was not frequent, 
although it was correlated with the most severe cases 
of congenital transmission. The results indicate that the 
absence of congenital disease markers (IgM and IgA) in 
newborns, even after confirming the absence with several 
techniques, does not constitute an exclusion criterion for 
toxoplasmosis.
Okay 
et al. 
(2009)
Clinics (Sao 
Paulo)
A total of 467 amniotic fluid 
samples from T. gondii IgM- and 
IgG-positive Brazilian pregnant 
women being treated for 1 to 6 
weeks at the time of amniocentesis 
(gestational ages of 14 to 25 
weeks).
The use of PCR for the diagnosis of fetal Toxoplasma 
infections in Brazil should be targeted to the B1 gene when 
only one gene can be amplified, preferably by nested 
amplification with primers B22/B23.
Bessières 
et al. 
(2009)
Mem Inst 
Oswaldo 
Cruz
From 1994-2005, in Toulouse 
University Hospital, France, 
amniocentesis was performed on 
352 pregnant women who were 
infected during pregnancy.
PCR performed on AF had the highest level of sensitivity 
and specificity for the diagnosis of CT. It permits an early 
diagnosis of most cases and should be recommended for 
identification of congenital infection. However, negative 
results cannot rule out fetal infection. Neonatal and 
postnatal screening identified these cases.
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Lago 
et al.   
(2009)
Sci. Med Prospective cross-sectional study 
of consecutive mothers and their 
liveborn infants within the first 
12 months of the implementation 
in a maternity ward of a routine 
consisting in screening for 
toxoplasmosis at delivery.
Maternal serologic screening at delivery was useful for the 
early detection of cases of congenital toxoplasmosis that 
would have otherwise gone undetected in the neonatal 
period, and allowed for earlier treatment of newborns 
with retinochoroiditis. The high prevalence of Toxoplasma 
gondii antibodies in pregnant women and of congenital 
toxoplasmosis justifies a prenatal screening program in this 
population.
Ferguson 
et al. 
(2008)
Ir Med J This study sought to estimate 
the prevalence of Toxoplasma 
susceptibility in pregnant women. 
As detection of Toxoplasma 
antibodies in neonatal blood 
reflects maternal exposure history, 
maternal antibody seroprevalence 
was determined using anonymized 
residual blood from newborn 
screening cards. A total of 20,252 
cards were tested in 1 year.
A total of 20 252 cards were tested which represented 
40.2% of registered live births in 1 year. 4 991 (24.6%) 
cards tested positive for Toxoplasma antibody. The mean 
seroprevalence in Ireland was 25%, ranging by county 
from 19.9% to 41.3% indicating that a significant majority 
of women of child bearing age remain susceptible to 
Toxoplasma infection in pregnancy.
Carellos 
et al.  
(2008)
Cad Saude 
Publica
This cross-sectional study of 
420 women in two public 
maternity hospitals from August 
2004 to May 2005 evaluated 
the application of a prenatal 
toxoplasmosis serological screening 
protocol in Belo Horizonte, Minas 
Gerais State, Brazil, and the 
information provided to susceptible 
pregnant women.
The initial testing identified 163 women as susceptible 
to toxoplasmosis: 44% of these did not undergo repeat 
serological testing, and 42% of them did not remember 
having received information on the prevention of 
toxoplasmosis infection. Orientation on risk factors 
included: avoiding contact with cats (95%), not handling or 
eating raw meat (70%), and washing vegetables carefully 
before consumption (53%).
Ciardelli 
et al.   
(2008)
Pediatr Infect 
Dis J
T lymphocyte proliferation, 
interferon (IFN)-gamma production 
and lymphocyte activation 
antigens expression were 
evaluated in 23 infected and 65 
uninfected neonates at different 
times, in the first year of life.
To the best of our knowledge, this is the first study 
reporting the concurrent evaluation of different 
immunologic assays for in vitro T cell responses to T. 
gondii antigens defining cut off values to improve accuracy 
and sensitivity. Our results underline the importance of 
evaluating cellular immunity to establish an early diagnosis 
of congenital toxoplasmosis.
Carral 
et al.  
(2008)
Medicina (B 
Aires)
Screening tests in pregnant 
women were done in nine 
different hospitals within the city 
of Buenos Aires and surroundings, 
where 19825 births between May 
1st, 2006 and April 30th, 2007 
were registered. Screening tests 
were done in 13632 pregnant 
women, using IgG and IgM 
determinations by ELISA.
The discovery of markers in blood of children and their 
absence in maternal blood is confirmatory of prenatal 
infection. Comparison of maternal and neonatal serology 
was useful in one case where IFI determinations ISAGA 
E and M were positive and negative in the child and in 
the mother, respectively. We conclude on the importance 
of serological screening during pregnancy and in the 
newborn, according to the experts' proposal explicit 
in the Argentine Consensus Congenital Toxoplasmosis. 
It was shown that the extension of the study allows 
more accurately diagnose acute infection, discard recent 
infections and avoid unnecessary treatments.
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Lago et 
al. (2007)
Paediatr 
Perinat 
Epidemiol
This prospective, cross-sectional 
study, conducted in 2002, tested 
a sample of 10 000 consecutive 
infants for T. gondii-specific 
IgM, using the same blood 
samples routinely obtained from 
all newborn infants treated 
by the public health system 
in Porto Alegre, in order to 
screen for phenylketonuria, 
congenital hypothyroidism and 
haemoglobinopathies.
In conclusion, in addition to finding a high prevalence 
of congenital toxoplasmosis in Porto Alegre, this study 
showed that neonatal screening identified cases of 
infection not detected by obtaining only one or two serum 
samples from pregnant women for T. gondii serology, 
mainly when infection was acquired and transmitted in 
late pregnancy. Maternal serology at delivery and neonatal 
screening were especially useful in the identification of 
infants with congenital toxoplasmosis when the mother did 
not receive regular prenatal serological testing or prenatal 
care.
Gilbert et 
al.(2007)
J Med Screen In this report, we confined 
analyses to infants born in the 
10 centres (in 3 countries) that 
operated prenatal screening. 
Neonatal screening centres could 
not be included as they did not 
follow up infants with negative 
results.
Poor performance of IgM and IgA tests in the newborn, 
particularly if the mother seroconverted in early 
pregnancy, casts doubt on the value of neonatal screening 
in industrialized countries where the risk of clinical 
manifestations during childhood is low. More accurate 
diagnostic tests are needed for newborns identified by 
prenatal screening.
Castilho-
Pelloso  
et al. 
(2007)
Rev Saude 
Publica
A retrospective study was 
conducted with IgM-anti-
Toxoplasma gondii reagent 
pregnant women and their 
children who attended the public 
health system in the state of 
Paraná, Southern Brazil, from 
January 2001 to December 2003. 
Information were obtained from 
clinical, laboratory (ELISA IgM/IgG) 
and ultrasonographic data and 
from interviews with the mothers.
The present study showed that the recommendations for 
monitoring this infection risk are not being systematically 
observed as some pregnant women with suspect 
laboratory results were not duly investigated, and some 
fetuses and newborns went without adequate monitoring 
for up to 12 months. Confirmed cases of congenital 
toxoplasmosis were detected only after birth in children 
with evident clinical abnormalities and the presence of 
IgM.
Isabel et 
al. (2007)
Sci. Med The results of the serological tests 
for toxoplasmosis in the prenatal 
care routine were analyzed in two 
groups of patients. One consisting 
of pregnant women with negative 
T. gondii specific IgM (n=200) and 
the other consisting of pregnant 
women with positive T. gondii-
specific IgM (n=33).
Even in the presence of a high specific T. gondii IgG avidity 
test in the first trimester of gestation, the antiparasitic 
treatment was instituted, demonstrating that the avidity 
test was not adequately utilized in the clinical practice.
Altcheh  
et al. 
(2006)
Diagn 
Microbiol 
Infect Dis
The reactivity values of Toxoplasma 
gondiiROP2, GRA4, and GRA7 
recombinant antigens (rAgs) were 
analyzed by immunoglobulin 
G (IgG) enzyme-linked 
immunosorbent assay (ELISA) in 
23 congenitally infected (I) and 36 
noninfected (NI) infants.
Our results indicate that rGRA4 and rGRA7 could have 
a potential to be used in the designing of novel and 
alternative diagnosis systems of CT. Between 1 and 4 
months, the presence of antibodies antirGRA7 suggests 
a congenital infection, whereas the absence of reactivity 
against rGRA4 would be suggestive of no infection.
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Reis et al. 
(2006)
Rev. Bras. 
Ginecol. 
Obstet
Specific IgG and IgM 
determinations were performed 
using fluorometric tests, with 
IgM capture. A second sample 
within two to three weeks was 
requested from all IgM-positive 
pregnant women and IgG avidity 
was performed in IgM-positive 
pregnant women at the beginning 
of pregnancy. Neonatal IgM 
was obtained when the delivery 
occurred at the institution.
A high prevalence of infection and congenital 
toxoplasmosis was found in pregnant women, even 
without data on seroconversion. Most of the IgM-positive 
serologies were related to past infection. The cost-benefit 
ratio of prenatal care in isolated samples may be optimized 
analyzing the risk of mother-to-child transmission in IgM-
positive pregnant women. When there is a risk, a neonatal 
IgM test must be requested and the newborn should be 
followed during the first year of life.
Discussion
Early diagnosis of congenital toxoplasmosis in preg-
nancy is crucial for proposing the most appropriate 
therapeutic approach in order to prevent late com-
plications. Different time steps in the microbiolo-
gical diagnosis of congenital toxoplasmosis, using 
different methods on different samples, may be in-
dividualized: during pregnancy, at birth, and during 
the first year of age [10].
In this way, CT diagnosis is confirmed if one of 
the following tests is positive: prenatal diagnosis 
based on the detection of Toxoplasma gondii in 
the amniotic fluid or neonatal diagnosis primarily 
based on the detection of neosynthesis of IgM 
and/or IgA specific antibodies in the infant serum 
[11]. Diagnosis of congenital toxoplasmosis is diffi-
cult due to the presence of maternal specific IgG 
anti-T. gondii antibodies in the newborn blood 
acquired through transplacental passage. Never-
theless, IgM and IgA antibodies do not cross the 
placental barrier and when they do so at birth, 
they have a lifespan of only five days, which allows 
them to be used as serological markers of vertical 
transmission [12].
Diagnostic methods
Serology
Serological tests are the fastest way to diagnose 
this infection since they can indicate the presen-
ce of two classes of immunoglobulins that do not 
cross placental barrier in the newborn or nursing 
infant serum: anti-T. gondii IgM and IgA [13, 12]. 
The diagnosis of congenital toxoplasmosis based 
on specific antibody detection is often delayed by 
the presence of maternal IgG and/or by the late 
production of specific antibodies in neonates as a 
consequence of immune system immaturity [9]. 
Serological tests that detect IgM class antibodies, 
present in recent infections are more commonly 
used for diagnosis of acute toxoplasmosis, but the 
most modern methods to detect minimal amounts 
for more than one year after the initial infection 
(residual IgM) [14]. Specific IgM is usually the first 
to be detected, in the first week post-infection. Its 
persistence for more than six months with great 
sensitivity testing as used is responsible for the ob-
served low in the diagnosis of acute infection, ex-
tremely important in pregnancy specificity. Thus, an 
isolated positive result has not an absolute value, 
as IgM can be "residual" or a false positive [15, 
4]. Therefore, when the first examination during 
gestation shows positive result, demonstrating the 
increase in antibody titers in samples with a mini-
mum interval of three weeks is recommended [14]. 
It is important to correctly interpret confirmed 
positive serology for anti-T gondii IgM by assessing 
whether their presence reflects an acute, a past 
infection with residual IgM antibodies, or has no 
meaning infection, be due to a cross reaction, in 
other words, false positive [16]. When it has iso-
lated sample or requested later in pregnancy, the 
levels of IgM must be linked to the levels of IgG 
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to the interpretation of serology consider both the 
dynamics of antibody formation as the space of 
a few months between conception and birth [4]. 
Postnatal serological diagnosis is usually performed 
by detecting specific IgM or IgA antibodies, but in 
a large percentage of congenitally infected children, 
these anti-bodies may be absent or produced in 
concentrations below the sensitivity thresholds of 
the methods available. Thus, in the absence of cli-
nical signs, the diagnosis may be delayed until the 
persistence or increase in Toxoplasma specific IgG 
is observable [17]. 
Recently, it was shown that serum samples from 
infants with CT and from their mothers might re-
cognize different parasite antigens, resulting in a 
differential profile by Western blot [18, 19, 20]. Fifty-
six mother-child pairs were enrolled in the study, in 
the period 2001-2008. All mothers were tested du-
ring pregnancy for specific IgG and IgM and for IgG 
avidity and, on the basis of the results, they were 
considered at risk for transmission. Seroconversion 
was observed during the course of pregnancy or 
strongly suggested by the presence of specific IgM 
and/or a threefold elevation of specific IgG titers 
in two serum samples taken at a distance of three 
weeks and analysed in parallel. The several serolo-
gical tests used to detect congenital toxoplasmosis 
Western blot was the most sensitive, demonstrating 
IgM with a greater sensitivity than the ISAGA tech-
nique and being the only technique to differentiate 
IgG of maternal origin from that of fetal and neo-
natal origin. In one case Western blot also proved 
useful for demonstrating active synthesis of IgG, as 
it showed bands of IgG directed against Toxoplasma 
antigens that were not present in the previous sam-
ple. The method enabled us to diagnose congenital 
toxoplasmosis in cases in which the infection had 
not been detected by classical serology techniques 
[17].
Demonstration of specific IgA anti-Toxoplasma 
antibodies have been the recommended antibody 
isotype for diagnosing neonatal infection because 
they can be as sensitive as, or more sensitive than, 
the demonstration of IgM antibodies [21, 12]. The 
IFI M is early positive and in most cases become 
negative in 6 to 12 months. The ISAGA is a more 
sensitive and specific technique for the detection of 
IgM and remains positive about 9 months to a year. 
With the same technique can be detected IgA and 
IgE. Both are characteristic of the acute stage, IgA 
become negative at about 7 months and IgE at 4-5 
months [22, 23, 24, 25]. By contrast, the presence 
of specific IgG antibodies may only repre-sent trans-
mission of maternal antibodies, which disappear in 
the first year of life [12]. The IgG antibody present 
in the newborn may reflect maternal infection due 
to passive transfer of antibodies. For this reason, 
tests for detecting IgA and IgM are commonly used 
for the diagnosis of infection in children [26, 27]. In 
general, in uninfected children, IgG levels decline 
gradually in the first months of life [28, 27].
IgM antibodies against Toxoplasma (Toxo-IgM) 
have been believed to be significant indicators for 
both recently acquired and congenital toxoplasmo-
sis [29]. Recently, identified several antigens for de-
tection of IgM antibodies using protein microarray 
displaying the polypeptides products of Toxoplas-
mic exons with well-characterized sera.[30, 29]. So 
far, however, there has not been any recognized 
protein of T. gondii that specifically reacts to IgM 
antibodies. Here, an antigen exclusively for detec-
tion of IgM antibodies screened by two-dimensional 
electrophoresis and mass spectrometry has been 
reported. The study identified 13 Toxoplasma pro-
teins probed by IgG antibodies and one (rhpotry 
protein 2 [ROP2]) by IgM antibodies with human 
sera of Toxo-IgM–-IgG+ and -IgM+-IgG–, respecti-
vely, which had been prescreened by Toxo-IgM and 
-IgG commercial kits from the suspected cases. Fo-
llowing cloning, expression, and purification of the 
fragment of ROP2186–533, an enzyme-linked im-
munosorbent assay with rROP2186–533 to measure 
IgM and IgG antibodies was developed. As a result, 
100%(48/48) of sera with Toxo-IgM+-IgG–showed 
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positive Toxo-IgM but none of them (0%) showed 
positive Toxo-IgG when rROP2186–533 was used as 
antigen. Neither Toxo-IgG nor Toxo-IgM antibodies 
were found when tested with 59 sera of Toxo-IgM–-
-IgG+. These results indicate that rROP2186–533 
could be used as an antigen that specifically capture 
Toxo-IgM antibodies and may have a high potential 
in the serological diagnosis of both acute acquired 
and congenital toxoplasmosis [29].
Demonstrated that positive specific IgA is more 
indicative for acute T. gondii infection than speci-
fic IgM as it disappears earlier (between 3 and 9 
months) while IgM remains at high levels for se-
veral months (up to 1 year), rendering inadequate 
sero-diagnosis of acute toxoplasmosis [31, 32]. It is 
important the joint detection of IgM and IgA in 
newborns because it can be positive for only one 
marker of prenatal infection macroglobulins [33, 
25]. The discovery of markers in blood of children 
and their absence in maternal blood confirm prena-
tal infection. Comparison of maternal and neonatal 
serology was useful in one case where IFI determi-
nations ISAGA E and M were positive to the child 
and negative to the mother [25]. Whenever mater-
nal serology indicate risk, should be asked IgM to 
newborn and accompany him during the first year 
of life. Integration between different levels of care 
in the public health system is needed so that you 
can achieve maximum efficiency in controlling ges-
tational and congenital toxoplasmosis [4].
Polymerase Chain Reaction - PCR
Conventional laboratory diagnosis of toxoplasmo-
sis is based on the presence of IgM and IgG anti-
Toxoplasma gondii antibodies; however, molecular 
techniques have emerged as alternative tools due to 
their increased sensitivity [5]. Performance variation 
among PCR systems in detecting Toxoplasma gondii 
has been extensively reported and associated with 
target genes, primer composition, amplification pa-
rameters, treatment during pregnancy, host genetic 
susceptibility and genotypes of different parasites 
according to geographical characteristics [34].
The superiority of PCR sensitivity in diagnosis of 
congenital toxoplasmosis refers to its ability in de-
tection of the parasite DNA (even if single) in blood 
[32]. A positive Toxoplasma gondii polymerase chain 
reaction (PCR) assay on an amniotic fluid (AF) sam-
ple entails radical changes in pre and post-natal 
management. However, the follow-up of pregnant 
women may be irregular, or mothers infected du-
ring pregnancy may refuse amniocentesis. In these 
situations and when prenatal diagnosis was nega-
tive, biological neonatal diagnosis of CT could be 
performed by molecular testing of different samples 
(AF, placenta, cord blood, peripheral blood) as well 
as comparative mother-child serologic tests [35].
The extreme diversity of methods and perfor-
mances of Toxoplasma PCR assays makes the use of 
commercial PCR kits an attractive alternative, as they 
offer a chance for standardization [2]. Toxoplasma 
PCR in amniotic fluid (AF) is the cornerstone of the 
antenatal diagnosis of congenital toxoplasmosis [36, 
37]. Highly sensitive methods are necessary because 
up to 46% of infected AF contain less than ten ta-
chyzoites per milliliter (T/ml) [38, 37]. We compared 
the performances of three molecular methods for 
the detection of Toxoplasma gondii DNA in amnio-
tic fluid: a commercial method using nested PCR 
and two laboratory-developed methods, one using 
conventional PCR and the other one real-time PCR. 
This evaluation was based upon a T. gondii DNA 
serial dilution assay, three amniotic fluid samples 
spiked with T. gondii at different concentrations, 
and a clinical cohort of 33 amniotic fluid samples. 
The T. gondii DNA serial dilution assay showed a 
much lower sensitivity for the commercial kit than 
for the laboratory-developed methods. Moreover, 
out of 12 proven congenital toxoplasmosis cases, 
91.7% were detected by the laboratory-developed 
assays, whereas only 50% were detected by the 
commercial kit. A lack of sensitivity of the method, 
partly due to the presence of PCR inhibitors, was 
the main drawback of the commercial method [2].
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Antenatal diagnosis of congenital toxoplasmosis 
relies on PCR in amniotic fluid. Because parasitic 
load is often low, DNA extraction must be optimi-
zed. Manual methods remain widespread although 
automated methods appear more effective. To opti-
mize NucliSens easyMAG, we evaluated the addition 
of proteinase K pre-treatment and the increase of 
the amount of silica particles used for the extraction. 
The optimized method was then compared to QIA-
amp DNA minikit on samples containing less than 25 
tachyzoites/ml. NucliSens easy-MAG DNA yield was 
improved after proteinase K pretreatment (p<0.01), 
but not with a higher silica particle input. The opti-
mized method yielded more positive PCRs than the 
manual method, especially for samples containing 5 
tachyzoites/ml or less (71% vs 26%, p<10-4). The 
DNA amount in samples found positive by PCR was 
higher after optimized automated extraction than 
after manual extraction (p<10-4). Proteinase K pre-
treatment should be added to extract DNA from 
amniotic fluid using NucliSens easyMAG [37].
Quantitative PCR is a prognostic marker of fe-
tal infection, since higher T. gondii concentrations 
in amniotic fluid are correlated with clinical signs 
in neonates [39, 8]. Congenital toxoplasmosis was 
diagnosed in 28 of the 102 cases. Specific IgM was 
detected in 57% of the babies at birth. A positive 
placental examination by PCR and mouse inocula-
tion was the only evidence of infection in 3 neona-
tes (11%) who were asymptomatic at birth. Parasites 
were detected more often when maternal infection 
was acquired during the third trimester of pregnan-
cy (P 0.01), regardless the type of treatment. A bet-
ter sensitivity of prenatal diagnosis when maternal 
infection was acquired at 17 to 21 weeks of ges-
tation, and a lower sensitivity when seroconversion 
occurred during the first trimester, but the excellent 
negative predictive value of their PCR test supports 
its use [40, 8].
A total of 467 amniotic fluid samples from T. 
gondii IgM- and IgG-positive Brazilian pregnant wo-
men being treated for 1 to 6 weeks at the time of 
amniocentesis (gestational ages of 14 to 25 weeks). 
One nested-B1-PCR and three one-round amplifica-
tion systems targeted to rDNA, AF146527 and the 
B1 gene were employed. The B1 gene PCR was far 
more sensitive than the AF146527 PCR, and the 
rDNA PCR was the least effective even though the 
rDNA had the most repetitive sequence. The use of 
PCR for the diagnosis of fetal Toxoplasma infections 
in Brazil should be targeted to the B1 gene when 
only one gene can be amplified, preferably by nes-
ted amplification with primers B22/B23 [34].
In a cohort of 12 consecutive neonates, polyme-
rase chain reaction (PCR) established the diagnosis 
of 5 of 6 cases of congenital toxoplasmosis and 
did so earlier than serologic methods. In conclusion, 
with a low false-negative rate and no false positive 
result, we validated that PCR on neonatal peripheral 
blood, i) can be performed routinely, ii) is able to 
affirm the diagnosis of CT, and iii) may be the first 
positive examination. Therefore, this unusual prac-
tice appears to be a useful alternative diagnostic 
approach [41]. 
PCR performed on AF had the highest levels of 
sensitivity and specificity for the diagnosis of CT. 
This permits an early diagnosis of most cases and 
should be recommended [42]. When polymerase 
chain reaction (PCR) of amniotic fluid, placenta, 
and/or cord blood is not available, the diagnosis of 
CT depends only on serologic follow-up after birth. 
The definite diagnosis is then difficult to assess and 
delayed [41]. 
Diagnosis in pregnant women
The infection by Toxoplasma gondii during preg-
nancy may cause fetal harm, such as miscarriages, 
retarded intrauterine growth, prematurity and neu-
rological and ophthalmic involvement [43, 27]. Af-
ter infection in pregnant women, the overall risk of 
fetal infection is 40%. However, this risk varies with 
the gestational age at which the woman became 
infected, being lower in the first quarter and highest 
in the third trimester [44, 27].
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The analysis of IgM and IgG antibodies for diag-
nosis are the most common tests that may be used 
routinely. Avidity tests should be applied on patients 
in whom both antibodies are identified as positive 
[3]. The avidity test is based on the affinity for the 
antigen having the specific immunoglobulins G ac-
cording to the time of infection. The IgG antibodies 
have low avidity for parasite antigens in the early 
phase of infection. With the maturation of the im-
mune response antibodies acquire greater avidity. It 
is interpreted as low avidity to values less than 20%, 
21-30% intermediate and high avidity higher than 
31%. A high avidity result indicates more than 12 
to 16 weeks of infection [45, 25]. The interpretation 
of the results lies in understanding the functional 
affinity of IgG antibodies to antigens is initially low 
after primary antigenic response, and increases sub-
sequently after maturation of the immune system 
[14].
The test avidity IgG anti-T.gondii was performed 
in 162 patients (92% of sample), lying high avidity 
(> 30%) in 144 (88.9%) and low avidity (≤ 30%) 
in 18 (11.1%) of pregnant women studied, being 
observed variation in the IgG avidity of 19.1% to 
74.7%. The association between the results of the 
IgG avidity tests for toxoplasmosis and fetal/neo-
natal confirmed infection showed that among 18 
women who had low avidity, 4 (22%) resulted in 
fetal/neonatal and 14 (78%) infection showed no 
infection congenital. Among the 144 women who 
had high avidity, 3 (2%) fetuses were infected and 
141 (98%) had no congenital infection by the cri-
teria described. There was association (p = 0.003) 
among the values of high avidity and absence of 
fetal/neonatal infection T. gondii in the studied sam-
ple. The prevalence ratio was 13.4 (95% confidence 
interval: 2.2 to 86.6), i.e., the pregnant women with 
high avidity were 13.4 times higher chance of your 
fetus/newborn not be infected [46].
The diagnosis of congenital toxoplasmosis may 
prove a difficult task, combining clinical characte-
ristics and results from a battery of serologic and 
molecular tests. From a prospective cohort of 344 
women who seroconverted for toxoplasmosis du-
ring pregnancy, 344 amniotic fluid, 264 placenta, 
and 216 cord blood samples were tested for diag-
nosis of congenital toxoplasmosis using the same 
PCR assay. The sensitivity and negative predictive 
value of the PCR assay using amniotic fluid were 
86.3% and 97.2%, respectively, and both speci-
ficity and positive predictive value were 100%. 
Using placenta and cord blood, sensitivities were 
79.5% and 21.2%, and specificities were 92% and 
100%, respectively. Thus, with a molecular diag-
nosis performing at a high level, and in spite of the 
persistence of false negatives, posttest risk cur-
ves using both negative and positive results prove 
highly informative, allowing a better assessment 
of the actual risk of congenital toxoplasmosis and 
finally an improved decision guide to treatment 
[10].
Congenital toxoplasmosis occurs only when the 
woman is infected during pregnancy and transmits 
the parasite to the fetus through the placenta. The 
passage is increased with advancing gestation, and 
is about 15%, 50% or 65% according to the trimes-
ter of pregnancy in which the infection occurs [47, 
25]. Seventy-three samples were collected from 57 
mother-child pairs followed-up for CT, either in Lille 2 
University Hospital or in the Cochin-Port Royal-Saint 
Vincent de Paul University Hospital group. Clinical 
monitoring for toxoplasmosis in these mother-child 
pairs showed 12% of termination of pregnancy, 11% 
of symptomatic CT and 77% of asymptomatic CT. 
The symptomatic and asymptomatic CT cases were 
confirmed by toxoplasmosis serological monitoring 
with an increase of immunoglobulin G (IgG) content 
in the first 12 months of life or a persistence of IgG 
after the first year of life or a presence of IgM and/
or IgA. CT occurred after maternal infection in the 
first (7%), second (58%) and third (35%) trimester 
of pregnancy [35]. 
There is controversy over the serological tests 
used in the diagnosis of acute toxoplasmosis in 
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pregnancy because decisions based on false-posi-
tive tests may result in pregnancy interruption and 
unnecessary treatment [48, 7]. To study the sero-
prevalence of Toxoplasma gondii infection among 
pregnant women living in Izmir, Turkey, 4,691 
pregnant women who were between 15 and 45 
years of age and in the first trimester of pregnancy 
were included in the study. IgG and IgM antibo-
dies were identified as negative (seronegative) in 
2.820 (60%). IgG antibody was identified as po-
sitive (seropositive) in 1.871 (39.9%) of the preg-
nant women of which anti Toxoplasma antibody 
results were evaluated. While IgM antibody was 
identified as negative in 1,823 of 1,871 pregnant 
women of which IgG was identified as positive, in 
48 (2.5%)of them IgM and IgG antibodies were 
both identified as positive. Intrauterine growth 
retardation and oligohydramnios developed in 
fetus in USG follow-up. The gestational age of 
fetus that was evaluated biometrically was found 
31 week rather than 35 weeks and AFI (amniotic 
fluid index) was measured as 40 in four quadrant 
measurement [3].
The diagnosis of acute infection in pregnancy 
is crucial because it is usually during this period 
that the pregnant woman is at risk of transmitting 
the disease to the fetus [49, 27]. First trimester 
infection is associated with 25% transmission with 
neurologic and ocular sequelae in 75%. Third tri-
mester infection is associated with more than 60% 
transmission but adverse sequelae in more than 
5%.3 Most infants in the latter group will be as-
ymptomatic at birth; some may display sub clinical 
disease on further evaluation. Without treatment, 
CT is a recurrent disease that may reactivate and 
progress at any time [50]. From 1994-2005, in 
Toulouse University Hospital, France, amniocente-
sis was performed on 352 pregnant women who 
were infected during pregnancy. Among the 275 
fetuses with follow-up, 66 (24%) were infected. 
The transmission rates of Toxoplasma gondii were 
7%, 24% and 59% in the first, second and third 
trimesters, respectively. The sensitivity and specifi-
city of PCR on amniotic fluid (AF) were 91% and 
99.5% and on placentas were 52% and 99%, res-
pectively. PCR performed on AF had the highest 
levels of sensitivity and specificity for the diagnosis 
of CT [42].
The prenatal diagnosis of toxoplasmosis is based 
on routine population screening or on the ultra-
sonographic recognition of characteristic findings 
associated with intrauterine infection followed by 
maternal or fetal laboratory tests [51]. There are 
additional reports of the imaging findings in CTX, 
onde pesquisadores describe ventriculomegaly and 
multiple large periventricular echogenic nodules in 
a patient diagnosed in the second trimester [52, 
51]. Physicians from Prenatal Diagnosis Units in 
ten Latin American countries were contacted and 
asked to provide data on fetuses with ultrasound 
findings suggestive of intrauterine infection and 
a positive diagnosis of CTX. Intracranial findings 
suggestive of CTX were identified in eight patients 
at a median gestational age of 31.5 weeks (range, 
24.4–34 weeks). All six survivors have choroido-
retinitis and intracranial calcifications, four suffer 
from developmental delay and three of these four 
children also suffer from seizures and blindness. 
Postnatal hydrocephaly was found in five children. 
Ventriculomegaly associated with multiple echo-
dense nodules is characteristic of severe fetal toxo-
plasmosis and carries a poor prognosis [51].
We analyzed data from pregnant women diag-
nosed with acute Toxoplasma infection in Lyon 
(France) from 1987 to 2008 and assessed how the 
risks of congenital toxoplasmosis and of clinical 
signs at age 3 years vary depending on GA at the 
time of maternal infection. Among 2048 mother-
infant pairs, 93.2% of mothers received prenatal 
treatment and 513 (24.7%) fetuses were infected. 
Probabilities of congenital infection were higher 
than 10% for maternal infections before 12 weeks 
of gestation, rose to 20.0% at 19 weeks, and then 
continued increasing to 52.3% and almost 70% 
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at 28 and 39 GA weeks, respectively. Because of 
a significant reduction in risk of clinical signs of 
congenital toxoplasmosis in infected children born 
from mothers diagnosed after 1995 when poly-
merase chain reaction testing on amniotic fluid 
was initiated (87/794 vs 46/1150; P = .012), pro-
babilities of clinical signs at 3 years were estima-
ted based on 1015 maternal infections diagnosed 
after 1995 including 207 infected children, with 
symptoms in 46 (22.2%) [53].
The ideal situation for the diagnosis of infec-
tion with T. gondii in pregnancy is serologic tests 
for toxoplasmosis in the early gestational period 
[54, 27] but often this is not possible, especially 
in Brazil, where few pregnant women start prena-
tal care in the first trimester [55, 56, 27]. For the 
diagnosis of acute T. gondii infection in pregnancy 
the realization of IgG avidity test in the first trimes-
ter in pregnant women with positive IgM serology 
should be considered. The presence of positive IgM 
serology as a test isolated, has limited value for 
detecting recent infection and should be used in 
combination with other complementary tests for 
the diagnosis of acute infection. The importance of 
analyzing the avidity index of IgG anti-T.gondii for 
making treatment decision rests on knowledge of 
the characteristics of clinical situations of pregnant 
women at the time of carrying out the serological 
tests [57, 45, 58, 46]. Such a strategy could re-
duce the need for treatment of pregnant women 
and follow-up of children who have ambulatorial 
suspicion.
Maternal serologic screening at delivery was use-
ful for the early detection of cases of congenital 
toxoplasmosis that would have otherwise gone 
undetected in the neonatal period, and allowed 
for earlier treatment of newborns with retinocho-
roiditis. The high prevalence of Toxoplasma gondii 
antibodies in pregnant women and of congenital 
toxoplasmosis justify a prenatal screening program 
in this population [59].
Diagnosis in neonates
Congenital infection by Toxoplasma gondii can lead 
to severe congenital defects such as hydrocephalus, 
mental retardation and retinochoroiditis, which can 
be present at birth or develop later in life [60, 61]. 
About 10% to 33% of prenatal infections result in 
abortion, neonatal death, or severe clinical signs at 
birth [62, 63, 20]. The clinical manifestation of the 
infant will depend of the gestational week when 
the mother acquired the infection and is characte-
rized by a broad spectrum of symptoms at birth, 
including varying degrees of neurologic, ophthal-
mologic and systemic involvement [60, 64]. More 
accurate diagnostic tests are needed for newborns 
identified by prenatal screening [65]. 
Early diagnosis is essential in order to determine 
the appropriate antibiotic therapy, but confirmatory 
tests are needed when specific IgMs or IgAs are 
not detected or to confirm potential false-positive 
results originating from maternal IgM or IgA leaks 
from the placenta in samples taken at birth or du-
ring the first 10 days of life [60, 61]. A single IgM 
and IgG serology test supported the majority of 
the decisions taken by the doctors regarding the-
rapeutic and prophylactic management. [7]. Poor 
performance of IgM and IgA tests in the newborn, 
particularly if the mother seroconverted in early 
pregnancy, casts doubt on the value of neonatal 
screening in industrialized countries where the risk 
of clinical manifestations during childhood is low. 
Recent reports indicate that congenital toxoplas-
mosis is more often symptomatic in South America 
than in Europe. We collected 15,333 samples from 
umbilical cord blood between the period of March 
2009 to May 2010 in 19 different hospitals and 
maternal-child health services from seven different 
cities. We applied an IgM ELISA assay (Vircell, Spain) 
to determine the frequency of IgM anti Toxoplas-
ma. The results in blood cord samples were con-
firmed either by western blot and repeated ELISA 
IgM assay. In a sub-sample of 1,613 children that 
were negative by the anti-Toxoplasma IgM assay, 
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the frequency of specific anti-Toxoplasma IgA by 
the ISAGA assay was determined. All children with 
positive samples by IgM, IgA, clinical diagnosis or 
treatment during pregnancy were recalled for con-
firmatory tests after day 10th of life [64]. 
We compared results of the first postnatal IgM or 
IgA test in infants with infected mothers identified 
by prenatal screening with the reference standard 
for congenital infection status of specific IgG status 
at one year of age. In all, 170 infected and 822 
uninfected infants were analysed. The first IgM or 
IgA test detected just over half the infants with con-
genital toxoplasmosis. Detection by IgM was lowest 
for newborns whose mothers seroconverted in the 
first or second trimesters [65]. More than two-thirds 
of infants detected by IgM or IgA were born to 
mothers who seroconverted in the third trimester. 
For prenatal screening, the poor performance of 
IgM and IgA tests means that more accurate tests 
or additional tests and follow up are required to 
decide on postnatal treatment in the 80% of new-
borns who have a negative IgM or IgA test result 
[66, 65]. The ISAGA IgM and IgA and ELISA IgA 
tests performed best, but positive results need to 
be quickly confirmed by testing a second sample as 
the detection rate was optimal up to two weeks of 
age and declined thereafter.
The children were submitted to clinical examina-
tions to assess macular, neurological and hearing 
signals. The WB results obtained were compared 
to the persistence of IgG antibodies at the end of 
12 months, which is regarded as the “gold stan-
dard” diagnosis of congenital toxoplasmosis. Of 
the 215 children, 177 had a confirmed congenital 
toxoplasmosis diagnosis and 38 were uninfected. 
IgG-WB showed a sensitivity of 73.5% and a spe-
cificity of 97.4%. IgM-WB showed a sensitivity of 
54.8% and a specificity of 94.7%. The IgG-WB 
and IgM-WB combination increased the sensitivi-
ty to 86.5%. The IgM-WB-positive children had a 
1.4-fold greater risk of presenting active macular 
lesions than did those that were IgM-WB-negative. 
The WB assay is a useful tool to confirm a diagnosis 
of congenital toxoplasmosis and that the IgM-WB-
positive results can indicate active macular lesions 
in newborn infants [67]. 
Eighty five mothers with Toxoplasma serocon-
version and their offspring were enrolled (among 
them, 2 spontaneous abortions were documented 
in the first trimester). Prenatal PCR diagnosis was 
carried out on 50 patients (60%), with 7 positive 
cases (14%). Morphological ultrasound scanning 
revealed anomalies in one fetus. Fourteen (17%) 
of the infants were infected at one-year serological 
follow-up. In 69 uninfected infants, anti-Toxoplasma 
IgG immunoblot analysis excluded infection within 
the 3 months in 18 infants (26%) and in the others 
within 6 months of life. Western blot analysis may 
help to evaluate infection within the 6 months of 
life. The accuracy of ultrasound imaging todetermi-
ne the brain damage in the fetus and newborns is 
doubtful, and should be combined with MR ima-
ging [68].
Approximately 80% of newborns with subclinical 
toxoplasmosis develop ocular sequelae during their 
lifetime [69, 70]. Toxoplasmosis seroprevalence was 
analyzed in 68 712 serum samples from 47 635 
pregnant women living in the catchment area of 
Hospital Miguel Servet during the period of 1992 to 
2008. Detection of toxoplasma-specific immunog-
lobulins (IgM, IgA, IgG) and IgG avidity studies were 
carried out in the microbiology laboratory. Fifteen 
thousand two hundred and seven were pregnant 
with IgG antibodies against T. gondii, which means 
31.9% immune women, and 32,428 were negati-
ve, representing 68.1% of the susceptible women. 
Among the positive women, 460 cases of women 
with high titers of IgG were observed, but not IgA 
or IgM accompanist. IgA was the serological marker 
more sensible in the detection of congenital infec-
tion in children [70].
A retrospective study was conducted with IgM-
anti-Toxoplasma gondii reagent pregnant women 
and their children who attended the public health 
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system in the state of Paraná, Southern Brazil, 
from January 2001 to December 2003. Informa-
tion were obtained from clinical, laboratory (ELISA 
IgM/IgG) and ultrasonographic data and from in-
terviews with the mothers. Two hundred and nine-
ty (1.0%) cases of suspected IgM-reagent infection 
were documented, with a prevalence of 10.7 IgM-
reagent women per 1,000 births. Frequent com-
plaints included headaches, visual disturbance and 
myalgia. Ultrasonography revealed abnormalities 
in 13 of 204 pregnancies. Among exposed chil-
dren, 44/208 were serologically followed up and 
all were IgG reagent, and three IgM-reagent cases 
showed clinical symptoms [7].
Real-time PCR analysis significantly improves the 
detection of T. gondii on amniotic fluid. It provides 
an accurate tool to predict fetal infection and to 
decide on appropriate treatment and surveillance. 
However, postnatal follow-up remains necessary 
in the first year of life to fully exclude infection in 
children for whom PCR results were negative [71]. 
Real-time PCR (qPCR) was positive in 72/150 (48%) 
blood samples of newborns with congenital toxo-
plasmosis. Among infants with active retinochoroi-
ditis, 68% had positive qPCR results, while positivi-
ty was 29% in the absence of ocular involvement. 
Positive qPCR was associated with the presence of 
retinochoroidal lesions, with an odds ratio of 2.8. T. 
gondii qPCR positivity is higher in infants with ocular 
involvement, particularly in those with active reti-
nochoroiditis. The parasite load in peripheral blood 
of congenitally infected infants within the first 2 
months of life is low, with no association between 
degree of parasitemia and the presence of retino-
choroidal lesions [72].
In another study, the confirmatory tests for 
congenital toxoplasmosis were evaluated in 23 
infected and 31 uninfected newborns. Conven-
tional polymerase chain reaction was better than 
real-time polymerase chain reaction, but did not 
identify additional cases. Avidity tests added 2 
new cases that were not identified by other cri-
teria. Overall sensitivity was 82.6%. Avidity as-
say, but not polymerase chain reaction, increased 
the sensitivity of confirmatory assays in congeni-
tal toxoplasmosis [61]. Laboratory contamination 
was discarded with negative controls during DNA 
extraction and PCR amplification. The presence 
of inhibitors such as hemoglobin, blood proteins 
and anticoagulants is a problem in blood-related 
products [73, 74, 61]. Consequently, there is a 
need to improve the diagnosis by evaluating al-
ternative confirmatory assays that could increase 
sensitivity or reduce the need for multiple criteria 
for diagnoses in newborns [61]. 
Neonates with congenital toxoplasmosis, even 
asymptomatic at birth, should be treated early to 
reduce long-term sequelae. Postnatal diagnosis of 
congenital toxoplasmosis is essential because pre-
natal diagnosis fails to detect approximately 15% of 
cases or cannot be performed when maternal in-
fection is acquired in late pregnancy [8]. Moreover, 
the sensitivity of CT diagnosis increased to 92.4% 
when prenatal diagnosis was combined with im-
mune blotting and to 95.8% with the addition of 
a conventional serological test (specific IgM/IgA) 
performed during the first month of life [11]. The 
sensitivity of IgM detection appeared to be rela-
ted to maternal treatment since IgM was positive 
in 43% and 75% when mothers were treated or 
not, respectively (P 0.01). Though 5/7 symptomatic 
infants had a positive placenta examination, there 
was no correlation between a positive placenta and 
the presence of clinical signs during the first year 
of life [8]. 
Recombinant antigens (rAg) have several advan-
tages compared with whole parasite extracts. Their 
costs are lower and they allow standardization 
procedures for serologic tests. The reactivity values 
of Toxoplasma gondii ROP2, GRA4, and GRA7 re-
combinant antigens (rAgs) were analyzed by immu-
noglobulin G (IgG) enzyme-linked immunosorbent 
assay (ELISA) in 23 congenitally infected (I) and 36 
noninfected (NI) infants. The results indicate that 
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rGRA4 and rGRA7 could have a potential to be 
used in the designing of novel and alternative diag-
nosis systems of CT. Between 1 and 4 months, the 
presence of antibodies antirGRA7 suggests a con-
genital infection, whereas the absence of reactivity 
against rGRA4 would be suggestive of no infection 
[20].
Diagnosis in infantis
T. gondii causes more severe ocular disease in con-
genitally infected children in Brazil than in Europe, 
with marked differences in frequency, size, and 
multiplicity of retinochoroidal lesions [75, 72]. The-
re are many difficulties in diagnosing congenital 
toxoplasmosis; for example, approximately 80% of 
infected newborns are asymptomatic at birth and 
may not present any manifestation of this infection 
for years. However, this does not prevent the late 
appearance of lesions, mainly in the eyes and brain, 
which can lead to blindness or mental retardation 
[76, 12]. In other cases, infected newborns appear 
to be totally asymptomatic at birth but are at risk 
of developing retinal diseases during childhood or 
adolescence [77, 78]. Advances in early diagnosis 
coupled with early and prolonged treatment du-
ring the first year of life appeared to modify the 
course of CT [32].
Testing of toxoplasma-specific antibodies in in-
fants identifies congenital toxoplasmosis during the 
first year of life [79]. Immunological markers can 
vary depending on the trimester of infection, and 
also maternal and neonatal therapeutic treatment 
received during pregnancy can block or retard the 
neonate’s immune response [80, 81, 68]. Therefore, 
even if comparison of maternal and neonatal IgG 
by immune blot does not show neonatal immune 
response to any Toxoplasma gondii antigens in the 
first trimester of life, this does not unequivocally 
exclude congenital infection. In fact, recent stu-
dies which have evaluated B-cell subsets and their 
functional development have shown that memory 
B-cells are very low at birth and increase signifi-
cantly at 6 months of life [82, 68]. The presence 
of maternal immunoglobulin G (IgG) antibodies in 
the newborn serum obscures and delays the diag-
nosis during the 1st months of age. Therefore, the 
infection should be confirmed by persistence of 
anti-T. gondii IgG after 8 months of age [63, 20]. 
Diagnosis at birth relies mainly on serological tests. 
Cell-mediated immunity plays the major role in re-
sistance to infection but is not routinely investigated 
for diagnostic purposes. Here, we describe a simple 
test based on the gamma interferon (IFN- ) response 
after stimulation of whole blood by crude parasitic 
antigens. For 62 infants under 1 year of age born to 
mothers who were infected during pregnancy, the 
sensitivity and specificity of the test were 94% and 
98%, respectively. For a cohort of 124 congenitally 
infected patients between 1 and 30 years of age, 
the sensitivity of the assay was 100%. We present 
a simple test based on IFN- secretion to assess cell-
mediated immunity in toxoplasmosis. As only 1 ml 
of blood is required to investigate humoral and ce-
llular immunity, our assay is well adapted for the 
study of congenital toxoplasmosis in infants. Using 
purified antigens or recombinant peptides may im-
prove the test performance [78].
In a retrospective study, serum Toxoplasma gon-
dii antibodies were measured in samples from 333 
infants, including 212 noninfected infants and 121 
infants with congenital toxoplasmosis. A total of 
1,157 umbilical cord blood and peripheral serum 
samples were analyzed. Liaison toxoplasma-speci-
fic IgG and IgM antibodies and the IgG avidity 
index were compared to the infection status of the 
infant, determined by the Sabin-Feldman dye test 
and immunosorbent agglutination assay—IgM. All 
noninfected infants were seronegative by Liaison 
IgG within the first year of life. In this study co-
hort, avidity did not show a potential diagnostic 
benefit for the detection of congenital infection. 
Despite the significant progress brought about by 
the analysis of these additional immunoblot bands, 
postnatal follow-up remains, however, necessary 
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in the first year of life to fully identify infected 
children [11]. The Liaison system is a valuable tool 
to monitor the serologic course of infants at risk. 
A final serologic confirmatory test is recommen-
ded to improve the rate of detection of congenital 
toxoplasmosis at 1 year of life [79]. 
Amniotic fluid samples were submitted to DNA 
extraction and amplification by the following 4 
Toxoplasma techniques performed with parasite B1 
gene primers: conventional PCR, nested-PCR, mul-
tiplex-nested-PCR, and real-time PCR. Fifty nine of 
the 100 infants had toxoplasmosis; 42 (71.2%) had 
IgM antibodies at birth but were asymptomatic, 
and the remaining 17 cases had non-detectable 
IgM antibodies but high IgG antibody titers that 
were associated with retinochoroiditis in 8 (13.5%) 
cases, abnormal cranial ultrasound in 5 (8.5%) ca-
ses, and signs/symptoms suggestive of infection in 
4 (6.8%) cases [5]. PCR had the highest levels of 
sensitivity and specificity in the diagnosis of (pre-
natal and postnatal) toxoplasmosis in comparison 
to serological tests [83, 42, 32]. Besides, PCR does 
not depend on the immune response of the pa-
tient as the serological tests do [84, 32]. Among 
the 4 proposed methods, the real-time PCR tech-
nique detected 58 of the 59 possible cases did 
not produce any false positive results and was the 
best-performing test [5]. 
Maternal serology at delivery and neonatal 
screening were especially useful in the identifica-
tion of infants with congenital toxoplasmosis when 
the mother did not receive regular prenatal serolo-
gical testing or prenatal care [85]. The presence of 
positive IgM serology as a test isolated, has limited 
value for detecting recent infection and should be 
used in combination with other complementary 
tests for the diagnosis of acute infection [27]. It 
will be from 217 newborns initially testing positive 
for specific IgM in filter paper dried blood spots 
were tested for specific IgM and IgG by ELFA-VI-
DAS®. Congenital toxoplasmosis was confirmed in 
175 and ruled out in 42 infants. The validity of the 
ELISA tests was determined using the persistence 
of IgG antibodies (ELFA-VIDAS® kit) at the end of 
12 months, which is considered the reference test 
for the diagnosis of congenital toxoplasmosis. All 
of the antigens showed high sensitivity and low 
specificity in detecting anti-T. gondii IgGt and IgG1 
and low sensitivity and high specificity in detecting 
IgG3 and IgG4. The assessment of IgG subclasses 
using recombinant antigens is a promising comple-
mentary tool for CT diagnosis, allowing the iden-
tification of a large number of newborns infected 
with T. gondii [1].
The neonatal serologic diagnosis of congenital 
toxoplasmosis is based on measurement of the IgM 
and IgA anti-T. gondii antibodies. However, 15-30% 
of the children infected do not present these anti-
bodies at birth and 10-20% of the infants testing 
positive for these antibodies are false-positives [86, 
67]. T lymphocyte proliferation, interferon (IFN) - 
production and lymphocyte activation antigens 
expression were evaluated in 23 infected and 65 
uninfected neonates at different times, in the first 
year of life. Evaluation of the specific T cell response 
allowed identification at 3 months of age or youn-
ger, 2 of 23 infected neonates, who had negative 
serologic tests. Moreover specific T lymphocyte ac-
tivity increased with age even in neonates under-
going therapy, suggesting that medical treatment 
does not affect lymphocyte response [9].
The severity of the congenital infection is inver-
sely proportional with the trimester in which the 
mother is infected with the disease [3]. Maternal 
prenatal recognition of acute gestational infection 
and early treatment of infants with congenital infec-
tion are important because prenatal and accurate 
postnatal antibiotic therapy improves the outcomes 
of infected infants [87].
Conclusion
Toxoplasmosis is usually asymptomatic for mother 
and the diagnosis accurate and early, and it’s essen-
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tial in the natural history of the disease. Its diagnosis 
currently comprises a spectrum of various methods, 
among which stand out the immunological/serolo-
gical, PCR and Western Blot
The immunological/serological methods indicate 
that a significant increase in the levels of specific an-
tibodies or seroconversion during pregnancy is asso-
ciated with recent exposure to the etiological agent 
of the disease. Furthermore, the antigen ROP2186-
533 is considered effective for detecting Toxo-IgM 
antibodies and can be used as a specific antigen 
to capture the IgM and to distinguish between la-
tent and recent infection with good efficiency. The 
PCR method has the advantage of the ability to 
detect parasite DNA in the amniotic fluid, placenta 
or umbilical cord blood not depending on the im-
mune response of those involved. The Western Blot 
method allows diagnose of congenital toxoplasmo-
sis in cases where the infection is not detectable 
by serology techniques. Studies also found the fre-
quency of IgM or IgA in cord blood as markers for 
congenital infections. 
The diagnosis beyond the neonatal period may 
be done by Western blot, which improved the 
time of diagnosis of toxoplasmosis in postnatal 
follow-up to about six months. We may associate 
this method of imaging tests such as ultrasound 
and MRI. The PCR also showed efficacy for that 
purpose. We conclude that the current status of 
health sciences, and technologies in terms of diag-
nosis of congenital toxoplasmosis are satisfactory. 
However, we do not rule out the need for develo-
ping new and revised methods allowing a specific 
research percentually more specific, accurate and 
especially early of the disease, as well as reasonably 
priced and applicable nationally in pre and postna-
tal screening programs.
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